Private preview. CertikLabs is pre-launch. The capabilities and specifications below are illustrative targets for the lab we intend to build. Accreditation in progress — target 2027.

Planned capabilities

Peptide lab testing, standardized.

Every batch will follow the same SOPs and output the same report structure — so vendors and customers will be able to compare apples to apples.

Reference photograph of an HPLC and LC-MS analytical chemistry workstation (illustrative)

Illustrative targets — not current operational metrics

HPLC purity resolution (target)

0.01%

Mass accuracy (target)

±0.1 Da

Concentration (target)

<2% CV

Endotoxin alignment (planned)

USP <85>

Planned assays and methods

HPLC Purity

Reverse-phase HPLC will quantify peptide purity with UV detection across configurable gradients.

Target detection: 214 nm · Target LOQ: 0.05%

LC-MS Identity

Liquid chromatography paired with mass spectrometry will confirm molecular weight against the expected target.

Target mass accuracy: ±0.1 Da

Concentration

Quantitative concentration verification will use calibrated reference standards, reported in mg/vial.

Target range: 0.1–50 mg · Target CV < 2%

Identity Confirmation

Cross-method confirmation will combine retention-time matching with mass-spectral fingerprinting.

Dual-method confirmation (planned)

Endotoxin / Sterility

Optional endotoxin screening (LAL) and sterility verification for injectable-grade product workflows.

USP <85> aligned (planned)

Custom Assays

Bespoke methods for novel peptides, conjugates, and complex matrices; method development included.

Target method dev: 2–3 weeks